miRNA-1231 Regulated EGFR Signaling: A Potential Therapeutic Target for Hepatocellular Carcinoma

Key Points

• EGFR signaling modulation shows potential as a therapeutic target in hepatocellular carcinoma, improving treatment options.
• Key evidence indicates that miRNA-1231 directly influences EGFR pathways, contributing to cancer development.
• Analysis of signaling pathways reveals the role of mirna-1231 in mediating therapeutic responses in cancer cells.
• Findings highlight the need for further validation in clinical settings to optimize cancer treatments.